chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"I'm confused,  I believe it (vaccine )was yesterday".; does not remember getting a card from vaccination provider; This is a spontaneous report from a non-contactable consumer (patient). A male patient of age 72 (units unspecified) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was not reported) via an unspecified route of administration on an unknown date in 2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included urinary flow. Concomitant medications included doxycycline calcium, atorvastatin calcium, doxazosin mesylate and finasteride taken for urinary flow. Patient received 1st dose of vaccine and became unsure if he received Pfizer or Moderna vaccine. He said he believes they told him they gave me Moderna. Patient said all his post vaccination paperwork says Pfizer and was sure he got the Pfizer drug. Patient continues to go back and forth about whether he received Pfizer or Moderna. He does not remember getting a card from vaccination provider and is asking for assistance with obtaining another card and confirming vaccination information (date received, manufacturing company). He is also confused about hand written date and time on top of paperwork, 10Mar2021 at 10 30am. Patient continues to voice he believes that was the date he got the 1st dose. Patient was confused about multiple topics and said maybe its medication he is taking, but this has been the most confusing day. Patient then repeats he was confused, he believed it (vaccine) was yesterday. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Administration of Expired Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine). On 08-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-237427 (Patient Link).
Chills; aches and pains; chest spasms; a fever a little shy of 101; hard to breathe; feel ill; activated all that discomfort; she thought she was having a heart attack; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 77-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on 20Jan2021 12:30 at single dose in right arm to prevent covid. Vaccination Facility Type was Health department. Medical history included rotator cuff challenge. There were no concomitant medications. No other vaccine was administered on the same date. There were no prior vaccinations within 4 weeks and no adverse events were following prior vaccinations. Patient was calling about Pfizer Covid vaccine. She had the first shot on 20Jan2021. She did not have a reaction. She went to go get her monthly massage on Saturday (23Jan2021). On Sunday morning (24Jan2021) she started to feel ill and she had to go the hospital. She confirmed she was not admitted to the hospital. She had chills, aches and pains, it felt like an elephant was on her chest, she had chest spasms, a fever a little shy of 101. She went to hospital and the doctor there told her she had covid since she had all the symptoms. She confirmed she did not have covid and had a negative covid test. She had chest x-ray and an EKG since she thought she was having a heart attack. Reported her massage was primarily on her left shoulder, it was a deep massage on that area since she had a rotator cuff challenge, massage was focused on that shoulder. She was thinking that the vaccine activated all that discomfort since she felt it from the left part of shoulder, went down to her chest like a v, and back up to her right shoulder. Every time she took a breath she had a chest spasm and it was hard to breathe. The events required a visit to emergency room. For treatment, they gave her medication to take called robaxin, it was an anti-spasm, and 800mg of ibuprofen. She took robaxin Sunday night, Monday, and she took one on Tuesday since she was feeling better. She was sensitive to medication. She felt dizzy and nausea from Robaxin. The patient had recovered from the events completely by Wednesday on 27Jan2021. She had a reminder to return for the second dose on 10Feb2021. She was asking if she should get the second dose.   Information about Batch/Lot number has been requested.
Information has been received on 06-JUN-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In June 2016, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 01-JUL-2016, the patient was treated by a physician for a blistering vesicular outbreak and decreased immune symptoms, which was then diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
This is medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 47-year-old female patient. On 14-Oct-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016) 0.5mL for the prevention of influenza. The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion as 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
Adminstered Moderna COVID19 vaccine to patient. 10 minutes after administration patient started to feel nauseous and faint. I gave the patient water and a fan. A few moments later she asked for a bag and began puking. I offered to call EMS but the patient refused. Once she was done puking she sat in her chair for another hour to rest. A friend had showed up to watch her. I watched the patient for 1 hour and she started to slowly get better. By the time the patient was released to go home she was laughing and feeling better.
Diarrhea; Abdominal cramping; This is a spontaneous report from a contactable physician. A 23-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 29Mar2021 (at the age of 23-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took clindamycin for wisdom tooth extraction 2 weeks prior to vaccine. On 30Mar2021, the patient experienced abdominal cramping first 24 hours after vaccination, resolved, then abdominal cramping with diarrhea started 5 days after vaccination (03Apr2021) and persisted for 3 days until today when seen in office and report made. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of abdominal cramp and diarrhea included oral hydration. The outcome of abdominal cramping occurred on 30Mar2021 was recovered in 2021, then it re-occurred on 03Apr2021 and not recovered; diarrhea was not recovered. This report was reported as non-serious by reporter.  Information about lot/batch number cannot be obtained. No further information expected.
Info has been received from a physician concerning a 17 year old male who on 8/16/04, was vaccinated with hepatitis A virus vaccine inactivated (lot 648219/0024P). On 9/13/04, the pt "came back to the office" with "minimal right upper quadrant pain". The pt also had "slightly elevated" liver enzymes (SGOT=41; SGPT=591 and IgM for hepatitis A was also positive. Unspecified medical attention was sought. No product quality complaint involved. Follow-up reported that the pt was "diagnosed with infectious mononucleosis, therefore increased LFT's cannot be attributed to vaccine (hepatitis A virus vaccine inactivated". Follow-up information from the physician stated that the pt "had mononucleosis and she does not think (the hepatitis A virus vaccine inactivated) had anything to do with the adverse event/elevated liver enzymes". No further info is expected.
Patient had received the Moderna vaccine and was in observation, when he started feeling lightheaded. I took his blood pressure and pulse. BP 115/70, pulse 48. I had him to stay seated and I would check him again. At that time RN came into the room and retook his BP- BP 90/40 P60 R18, Pt then placed onto the floor and feet elevated. Pt became very pale and continued to complain of lightheadedness. we continued to observe pt. Pt explained that he was feeling a lot better. Continued to lay on the floor with feet elevated. BP 138/92 P-62 R-16. Color returned to normal Pt reported that he was feeling better . Placed pt in upright position and RN helped him to chair. RN continued to monitor pt for 15 minutes and pt was sent home. He had no more lightheadedness before he left.
Information has been received from a physician concerning a female with a history of obesity who was vaccinated SC with a second dose of VARIVAX (Merck). Concomitant therapy included VERO, PEDIARIX, and MENACTRA. In approximately February 2008, the patient experienced severe swelling at the injection site and developed a rash that ran down their arm. The outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
muscle pain; This case was reported by a pharmacist via call center representative and described the occurrence of myalgia of lower extremities in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th May 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 9 months after receiving Shingrix, the patient experienced myalgia of lower extremities. On an unknown date, the outcome of the myalgia of lower extremities was recovered/resolved.   It was unknown if the reporter considered the myalgia of lower extremities to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced muscle pain in his legs. The reporting pharmacist would like to know if there are any issues with the patient getting the 2nd dose.  The reporter consented to follow up.
Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer COVID Vaccines on 4/29/2021, 5/20/2021 and 11/22/2021. Presented to ED on 7/3 with SOB and malaise 2/2 COVID in a-fib with RVR in 150s tx'd w/amiodarone gtt w/improvement. O2 saturation down to 82% req'd NC. During stay pt also experienced KI. Pt cont'd to decline. Rapid response called 7/14 for a-fib and increasing O2 requirements. Transitioned to comfort care and moved to inpatient hospice. Expired on 7/18/22. Pt was tx'd with cefepime, ceftriaxone, remdesivir, and decadron.
I was pregnant with my fourth pregnancy (three healthy pregnancies  and births previous to this fourth pregnancy, no history of miscarriage) and was due October 28, 2021. I had not yet had my first appointment with my doctor as that occurred the first week in April. I had my first vaccination on March 22 and it is estimated that the baby died around March 25 due to its size. When I went for my first appointment on April 8 there was no heartbeat. While it is unlikely the vaccine caused this adverse reaction, I wanted to have it documented in the rare even there were other similar complications.
Tdap was administered first. Site: upper right deltoid. Fluarix Quadrivalent was administered second intramuscularly. Site: lower deltoid. Immediately after administering Fluarix  a firm lump formed at injection site. It grew quickly to  about the size of about a quarter. The injection was given through a large tattoo so that it was difficult to assess the color of the lump. The lump bulged out from under the patient's skin. The reaction was localized to the Fluarix injection site. No signs or symptoms of anaphylaxis. This was the patient's first flu shot. Patient denies SOB/wheezing or any respiratory symptoms. No periorbital edema.  No history of prior injection reactions. Diphenhydramine 50 mg oral was administered. Ice pack applied to site.  Instructed to take cetirizine 10 mg daily for 5 to 7 days.  Ice 15-20 minutes several times daily.  Discharged ambulatory (mother driving him home) with no respiratory S&S.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patient's medical history or concurrent conditions were not reported.     On an unknown dates, the patients were vaccinated with GARDASIL 9 for prophylaxis (dosage information, route and lot number were not informed). Information regarding concomitant medication was not provided. The registered nurse reported a temperature excursion that lasted 22 hours. However the reporter was unable to provide a temperature range for the excursion, was not even sure if it went beyond the (>46F to <77F) range or even out of the (36F to 46F range) because her data logger malfunctioned. It could not be ruled out if the vaccines experienced out of range temperatures or not. The nurse also stated that the temperature was in recommended storage range prior to the malfunction of the data logger. No adverse effects reported. There was no product quality complaint involved. This is one of two cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA000376:
Approximately 5 minutes after vaccine administration, patient began to feel faint and lightheaded, and began to slump forward in her chair. She straightened up quickly, did not fall and did not completely lose consciousness. The patient then started vomiting. Taking blood pressure at this point yielded 78/48 with a pulse of 68. Patients mother walked the patient out and stated they were going to the emergency room.
Administered 2nd COVID vaccine Friday 1/29/2021. Nothing out of the ordinary. The next morning on Saturday 1/30/2021, he was found on the floor in his room- responsive, but disoriented. He could not move his left side. The ambulance was called immediately.
The night of the second COVID-19 shot resulted in the normal arm pain as well as flu-like symptoms. However, the flu-like symptoms persisted through the next day (27th) to such an intensity that I could not leave the bed. While some of the headache aspects dwindled on the 28th, my joints felt rusted and difficult to move, and they had some slight pain (all over the body). The most pervasive symptom was fatigue which was intense enough that I was mostly resigned to taking off work on the 29th and staying in bed most of the 29th and 30th. I was able to move about the house on March 31, but even as of April 1st I was still short of breath and fatigued enough that just walking to the garage (roughly 200 ft away) required that I stopped to sit down multiple times. It is worth noting that I am not obese or prone to lack of energy. For perspective on energy and shortness of breath, I did not feel safe to drive until roughly April 3rd.  These details are to the best of my memory, and I didn't consider them important at the time because they didn't seem to align with reported symptoms.
1st shot ,fatigue, Highs Mostly Lows in energy, not myself, having trouble waking up even at 11am..effects slowly diminished,but could be felt for 3 weeks. My only brother reported same reaction to 1st shot!!  2nd shot was a breeze, hardly anything to report!! took off a few days of work, even after a week
Pt had large red rash on rt upper arm that was noticed 48 hr post injection. MD gave verbal order for BENADRYL and pt had no c/o itching or pain at the site. Pt was sent here from the MD office to report the reaction. MD stated that pt had previous PNEUMOVAX in 2010.
Had varicella #2 yesterday. One side of face last night was painful and whole face this am was swelling.  No problem with breathing.
3 to 4 days duration of nausea.vomiting, diarrhea, dyspnea on exertion and weakness and fevers. pt had Covid Pt had both Moderna vaccines
Positive covid test; shortness of breathe; diarrhea; no eating; tired; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Positive covid test) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Hypertension.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced COVID-19 (Positive covid test) (seriousness criterion hospitalization). On an unknown date, the patient experienced DYSPNOEA (shortness of breathe), DIARRHOEA (diarrhea), DECREASED APPETITE (no eating) and FATIGUE (tired). The patient was hospitalized from 17-Feb-2021 to 21-Feb-2021 due to COVID-19. At the time of the report, COVID-19 (Positive covid test), DYSPNOEA (shortness of breathe), DIARRHOEA (diarrhea), DECREASED APPETITE (no eating) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: No specific follow-up information recorded.
Worsening diarrhea since 1st dose; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Worsening diarrhea since 1st dose) and HEADACHE (Bad headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced DIARRHOEA (Worsening diarrhea since 1st dose) and HEADACHE (Bad headache). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) ongoing since an unknown date for Diarrhea aggravated, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Worsening diarrhea since 1st dose) had resolved and HEADACHE (Bad headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant information  provided.  Treatment included Gatorade for Dehydration.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up information received contains updated information of outcome of diarrhea, action taken with the suspect and treatment medication.
A report was received from a healthcare professional on 10/20/2003 concerning an unspecified number of vaccinees less than 4 years of age who received Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received Fluvirin.  The reporter was not aware of any adverse symptoms occurring at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 11/10/2003: A follow up report was received from a healthcare professional indicating that a 3 year old male vaccinee received Fluvirin on 10/07/2003.
One minute following the shot, began to experience rapidly increased heat and pressure from my chest/breastbone area. Akin to having a heart attack with a feeling of a die pumped from a CAT scan. Sweating, dizziness, and rapid heart beat. Paramedics on site measured my vitals within 3 minutes and reported pulse over 100, BP at 160/100. This feeling gradually subsided over the next 15 minutes but the chest felt as if it was punched. Day 2 and day 3. Extreme fatigue and uncontrolled Heartburn.  Was unable to quench heartburn that radiated through my neck, face, whole chest. Took 4000 mg of tums and Pepsid 20mg . Heartburn feeling persisted for 5-7 hours both days.
Local soreness and mother noticed tiny bumps near the site of the injection that night (about 12 hours after injection)
pt devel inj site rxn characterized by redness, swelling & pain p/vax;
pt brought to ED for weakness, difficulty ambulating and decreased UOP; admitted; positive test for COVID; treated with ABX; transferred to ICU; experienced A Fib but converted to NSR; acute renal failure requiring hemodialysis; A Fib with RVR during hemodialysis; DNR; pt passed away in the hospital
Patient was given an extra dose of Meningococcal B vaccine. No adverse symptoms were found.
Patient noticed rash in area vaccine was administered this morning when she woke up. She states that she only notices any feeling of mild pain/swelling if she touches it; otherwise it does not bother her. Rash is approx. 2 inches x 0.5 inches. Patient also stated she received the intradermal flu vaccine from her physician's office about 2 weeks ago and had a very similar reaction the next day.
I believe I have the "COVID Arm."  This is almost 7 or 8 days on the dot and I started experiencing pain and large swelling at the vaccination site along with itchiness.
Localized reaction at influenza vaccine administration site (R) deltoid - no pain - pruritus and erythema with pinpoint bumps - Rx with Hydrocortisone cream.
Numbness traveled up from injection area to shoulder, neck, jaw, ear, temple, brow and only left side of tongue. All within a period of one hour. 24 hours later tongue swelled and groun are. Numbness continued. Administred Benadryl every 6-8 hours during this time. 48 hours now, tongue is slightly swelled, numbness subsided.
REDNESS, SWELLING, AND SLIGHT PAIN AROUND INJECTION SITE LEFT LEG ONLY, ONSET 36 HOURS AFTER INJECTION. PATIENT WAS SEEN AGAIN IN THE OFFICE, FELT TO HAVE A LOCAL REACTION, ADVISED TO TREAT WITH WARM TOWELS AND IBUPROFEN AND TO CALL IF REDNESS PROGRESSED OR IF THE LEG BECAME EXTREMELY TENDER. SHE WAS ABLE TO WALK AND WAS PLAYFUL.
Itchy red rash on left arm, about 3 inches tall, 2 inches wide...appeared about 1 week after the injection  Have applied Benadryl spray, taken Benadryl tablets Rash is much better but still visible